Results 121 to 130 of about 11,802 (200)

IMPACT OF THE COVID-19 PANDEMIC ON THE EVOLUTION OF THE INCIDENCE DENSITY OF MULTIDRUG-RESISTANT BACTERIA IN A HIGH-COMPLEXITY PRIVATE HOSPITAL (2019–2025)

Brazilian Journal of Infectious Diseases
Introduction/Objective: The COVID-19 pandemic has impacted bacterial resistance, especially among bacteria prioritized by the World Health Organization.
Emerson dos Santos Hoffmann, Amanda de Farias Balbinot, Nadiana Inocente, Rodrigo Chiavaro da Fonseca, Jaysa Pizzi, Renata Dortzbacher Feil Klafke, Luiza Martinez Perez, Erik Menezes Martins, Letícia Camargo Marinho, Guilherme Geraldo Lovato Sório, Alexandre Prehn Zavascki, Beatriz Arns   +11 more
doaj   +1 more source

Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19 [version 2; peer review: 2 approved]

F1000Research
The ongoing spread of antimicrobial resistance has complicated the treatment of bacterial hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Dalal Hammoudi Halat, Carole Ayoub Moubareck   +1 more
doaj   +1 more source

Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysis

Antimicrobial resistance is a significant public health issue. In addressing the threat of multidrug resistant bacterial infections, carbapenems have been used.
Ahmad A. Alshehri, Ahmad Adebayo Irekeola   +1 more
core   +1 more source

Efficacy of eravacycline on carbapenem resistant Enterobacterales in vitro

, 2019
The main obstacle in treatment of infections caused by carbapenem-resistant Enterobacterales (CRE) are limited treatment options. The novel antimicrobial agents other than β-lactams with activity not being dependent on β-lactamase class are especially important.
openaire   +1 more source

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales

BACKGROUND: Both carbapenem and piperacillin-tazobactam (TZP) use have been reported as risk factors for carbepenem-resistant Enterobacterales (CRE) infections.
Gökçen Telli, Gülçin Telli Dizman, Pınar Zarakolu, Gülşen Hazırolan, Murat Akova, Gökhan Metan, Tuğba Pamukçu   +6 more
core   +1 more source

The Practicability of Carbapenem-resistant Enterobacterales Surveillance Culture

Korean Journal of Healthcare-Associated Infection Control and Prevention, 2023
openaire   +1 more source

Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon. [PDF]

JAC Antimicrob Resist
Tannous J, Saliba R, Mghames A, Tokajian S, Attieh R, Jisr T, Barhoun J, Diab MK, Shakra DA, Mokhbat J, Al Souheil A, Zorkot W, Jaffal F, Salman H, Husni R, Rahban H, Khoury E, Mohsen Z, Abboud E, Youssef M, Karayakoupoglo G, Fawaz I, Houmani M, Abdallah D, Moghnieh R.   +24 more
europepmc   +1 more source

Increase in bla_NDM among Carbapenemase-Producing, Carbapenem-Resistant Enterobacterales, United States, 2016-2023. [PDF]

Emerg Infect Dis
Ansari UA, Campbell D, Brandenburg JM, Duffy N, Grass JE, Guh AY, Lutgring JD, Elkins CA, Karlsson M, Gargis AS, HAIC MuGSI Working Group.   +10 more
europepmc   +1 more source

Molecular epidemiology and clinical profiles of carbapenem-resistant Enterobacterales in neonates from two large children's hospitals in southwestern China. [PDF]

Front Cell Infect Microbiol
Zhang J, Wang H, Chang H, Wang H, Zhuo Y, Xu X, Zhang X, Zhang Q.   +7 more
europepmc   +1 more source

Carbapenem-resistant Enterobacterales bacteraemia at a tertiary hospital: A five-year review. [PDF]

S Afr J Infect Dis
Marais D, van der Westhuizen B, Barrett CL, Potgieter S.   +3 more
europepmc   +1 more source